Beverly Davidson Advances Huntington’s Disease Gene Therapy at ASGCT 2026
BOSTON – Geneticist Beverly Davidson, PhD, was honored with the 2026 Outstanding Achievement Award from…
Newswire
ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative
BOSTON — In a potentially significant advance for the genome editing field, researchers from the…
India’s pharma industry is going global. But can it catch up to China?
A record Sun Pharma acquisition signals global ambitions. However, significant infrastructure, capital, and policy gaps…
ASGCT 2026: Rare Instance of AAV Integration into Human Genome Linked to Brain Tumor
BOSTON — A team at Children’s Hospital of Philadelphia (CHOP) led by Rebecca Ahrens-Niklas, MD,…
ECO 2026: Tirzepatide Shows Potential for T1D Treatment
During ECO 2026, a pivotal study was presented that highlights the potential of tirzepatide, a…
Eisai’s Slow Push Toward Blockbuster Leqembi Sales Gains Steam with $900M Forecast
Eisai has reported a significant increase in sales for its Alzheimer’s disease treatment, Leqembi, forecasting…
Arna Pharma and Slate Run Complete JV for New US Company
Arna Pharma and Slate Run Pharmaceuticals have finalized their joint venture to establish a new…
SCOTUS Temporarily Restores Telehealth Access to Abortion Pill Mifepristone
The U.S. Supreme Court has issued an emergency order, temporarily blocking a federal appeals court…
Kyowa Kirin secures FDA approval for Crysvita dosing update
Kyowa Kirin has received FDA approval for an updated dosing regimen for Crysvita, enhancing the…
As biologics dominate biopharma pipelines, manufacturing hurdles trip up new launches: report
As biologics have increasingly superseded small molecules in the biopharma industry’s pipeline, the mounting complexity…